Clinical trial
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of…
NCT00270517 · Enanta Pharmaceuticals, Inc, Industry · Unknown status
Key facts
| NCT number | NCT00270517 |
|---|---|
| Title | Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia |
| Official title | A Randomized, Double-Blinded, Parallel Group, Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia |
| Lead sponsor | Enanta Pharmaceuticals, Inc, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Community Acquired Pneumonia |
| Intervention type | Drug |
| Interventions | EDP-420 / Duration of Treatment - 3 days, Telithromycin / Duration of Treatment - 7 days |
| Enrollment | 250 |
| Start date | Dec 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Dec 28, 2005 |
| Last update posted | Sep 19, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: